HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rui D S Prediger Selected Research

Body Weight (Weight, Body)

12/2010Chronic caffeine treatment during prepubertal period confers long-term cognitive benefits in adult spontaneously hypertensive rats (SHR), an animal model of attention deficit hyperactivity disorder (ADHD).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rui D S Prediger Research Topics

Disease

10Parkinson Disease (Parkinson's Disease)
12/2012 - 12/2006
8Cognitive Dysfunction
01/2021 - 06/2005
7Memory Disorders (Memory Loss)
08/2011 - 02/2006
4Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
12/2010 - 12/2005
3Neuroinflammatory Diseases
11/2021 - 12/2010
3Inflammation (Inflammations)
07/2011 - 03/2010
3Alzheimer Disease (Alzheimer's Disease)
05/2010 - 05/2007
3Ataxia (Dyssynergia)
10/2006 - 09/2004
2Pain (Aches)
07/2011 - 09/2010
2Dyskinesias (Dyskinesia)
01/2011 - 01/2010
2Amyloid Plaque
03/2010 - 02/2007
1Mental Disorders (Mental Disorder)
01/2021
1Nervous System Diseases (Neurological Disorders)
01/2021
1Brain Ischemia (Cerebral Ischemia)
01/2021
1Abdominal Pain (Pain, Abdominal)
08/2013
1Craniocerebral Trauma (Head Injury)
07/2012
1Bipolar Disorder (Manic Depressive Psychosis)
04/2012
1Temporal Lobe Epilepsy
04/2011
1Epilepsy (Aura)
04/2011
1Hippocampal Sclerosis
04/2011
1Status Epilepticus (Complex Partial Status Epilepticus)
04/2011
1Psychotic Disorders (Schizoaffective Disorder)
01/2011
1Mitochondrial Diseases (Mitochondrial Disease)
01/2011
1Body Weight (Weight, Body)
12/2010
1Brain Diseases (Brain Disorder)
05/2010
1Dementia (Dementias)
03/2010
1Amnesia (Dissociative Amnesia)
03/2010
1Down Syndrome (Down's Syndrome)
12/2008
1Anxiety Disorders (Anxiety Disorder)
11/2006
1Hypertension (High Blood Pressure)
04/2005
1Alcoholism (Alcohol Abuse)
09/2004

Drug/Important Bio-Agent (IBA)

71- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
12/2012 - 12/2006
5Caffeine (No Doz)FDA LinkGeneric
12/2010 - 04/2005
5Peptides (Polypeptides)IBA
12/2010 - 02/2007
5Amyloid beta-PeptidesIBA
09/2010 - 02/2007
4Purinergic P1 Receptors (Adenosine Receptor)IBA
03/2009 - 09/2004
3Pharmaceutical PreparationsIBA
12/2010 - 06/2005
3Purinergic P1 Receptor AntagonistsIBA
03/2009 - 04/2005
3Hypnotics and Sedatives (Sedatives)IBA
10/2006 - 09/2004
3Ethanol (Ethyl Alcohol)IBA
10/2006 - 09/2004
2Atorvastatin (Lipitor)FDA Link
11/2021 - 12/2010
2Neuroprotective AgentsIBA
04/2012 - 01/2011
2Dopamine (Intropin)FDA LinkGeneric
08/2011 - 01/2010
2Pilocarpine (Ocusert)FDA LinkGeneric
04/2011 - 02/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2010 - 05/2007
2Cannabinoid Receptor AgonistsIBA
06/2007 - 11/2006
2Anti-Anxiety Agents (Anxiolytics)IBA
10/2005 - 09/2004
1Propolis (Bee Bread)IBA
01/2021
1pinocembrinIBA
01/2021
1AnkyrinsIBA
08/2013
1Irritants (Vesicants)IBA
08/2013
1Biomarkers (Surrogate Marker)IBA
07/2012
1LithiumIBA
04/2012
1Valproic Acid (Depakote)FDA LinkGeneric
04/2012
1Agrochemicals (Agricultural Chemicals)IBA
01/2012
1Heparin (Liquaemin)FDA LinkGeneric
08/2011
1MidkineIBA
08/2011
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2011
1Therapeutic UsesIBA
07/2011
1CarrageenanIBA
07/2011
1Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA
04/2011
1proanthocyanidinIBA
12/2010
1Glutamic Acid (Glutamate)FDA Link
12/2010
1Desipramine (Pertofrane)FDA LinkGeneric
09/2010
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2010
1Proteins (Proteins, Gene)FDA Link
05/2010
1Phosphatidylinositols (Phosphatidylinositol)IBA
03/2010
1Scopolamine (Hyoscine)FDA Link
03/2010
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
03/2010
15- quinoxalin- 6- ylmethylenethiazolidine- 2,4- dioneIBA
03/2010
1amyloid beta-protein (1-40)IBA
03/2010
1istradefyllineIBA
01/2010
1Adenosine A2 Receptor AntagonistsIBA
01/2010
1Reserpine (Serpasil)FDA Link
08/2009
1Methylphenidate (Ritalin)FDA LinkGeneric
03/2009
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2008
1CannabinoidsIBA
06/2007
1(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
06/2007
1Glutathione (Reduced Glutathione)IBA
02/2007
1AntioxidantsIBA
02/2007
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
02/2006
1Cholinergic Agents (Cholinergics)IBA
02/2006
1Adenosine (Adenocard)FDA LinkGeneric
10/2005
1Dopamine Receptors (Dopamine Receptor)IBA
10/2005
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
04/2005
1ZM 241385 (ZM241385)IBA
04/2005
1Adenosine A1 ReceptorIBA
04/2005
11,3-dipropyl-8-cyclopentylxanthineIBA
04/2005
1Phenol (Carbolic Acid)FDA Link
04/2005

Therapy/Procedure

4Intranasal Administration
01/2012 - 12/2006
2Therapeutics
01/2011 - 12/2010
1Traditional Medicine (Folk Remedies)
07/2011